Impact of concurrent diabetes on the intensity of systematic inflammatory response syndrome and nutritive status of pulmonary tuberculosis patients
Abstract
About the Authors
G. O. KaminskayaRussian Federation
Moscow
R. Yu. Аbdullaev
Russian Federation
Moscow
O. G. Komissarova
Russian Federation
Moscow
O. O. Konyaeva
Russian Federation
Moscow
O. O. Berezhnaya
Russian Federation
Moscow
References
1. Kovaleva S.I. Sakharny diabet i tuberkulez (dispansernoe issledovanie). Diss. dokt. med. nauk. [Diabetes and tuberculosis (dispensary follow-up). Doct. Diss.]. Moscow, 1979.
2. Sveklina T.S., Talantseva M.S., Barsukov А.V. Metabolic syndrome and inflammation: actual issues of pathogenesis. Klin.-Lab. Diagn., 2013, no. 3, pp. 7-10. (In Russ.)
3. Smurova T.F., Kovaleva S.I. Tuberkulez i sakharny diabet. [Tuberculosis and diabetes.] Moscow, 2007.
4. Teti T. Sing S., Fonseka V. Metabolicheskiy sindrom i peroral’nye sakharosnizhayushhie sredstva. Metabolich. sindrom. (Russ. Ed.: Metabolic syndrome and oral sugar-reducing agents. Metabolic syndrome). Moscow, 2011, pp. 83-101.
5. Chereshnev V.А., Gusev E.Yu., Yurchenko L.N. System inflammation – myth or reality? Vestnik RAN, 2004, vol. 74, no. 3, pp. 219-225. (In Russ.)
6. Harries A.D. TB-diabetes collaborative activities – from evidence to action. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1, pp. 5.
7. Komissarova O.G., Konyayeva O.O., Abdullaev R. Efficacy of MDR-tuberculosis in patients with different types of diabetes mellitus. Int.J.Tuberc. Lung. Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S309
8. Kushner J. The acute phase response: general aspects. Bullieres Clin.Rheumatol., 1994, vol. 8, no. 3, pp. 513-530.
9. Kushner J. Regulation of the acute phase response by cytokines. Prospect. Biol. Med., 1993, vol. 36, no. 4, pp. 611-622.
10. Nystrom P.O. The systemic inflammatory response syndrome, definition and aetiology. J. Antimicrob. Chemother., 1998, vol. 41, suppl. A, pp. 1-7.
11. Punga V., Yakimova M., Rusakova L. Impact of diabetes mellitus on epidemiological rates of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S308.
12. Robertson C.M., Coopersmith C.M. The systemic inflammatory response syndrome. Microbes Infect., 2006, vol. 8, no. 5, pp. 1382-1389.
13. Ruslami R., Ugarte-Gil C., WalzlG. et al. TANDEM field studies on TB and diabetes mellitus in Peru, South Africa, Romania and Indonesia. Int.J.Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S6.
14. Unsal A., Aksaray S., Koksal D., Sipit T. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis. Postgrad Med., 2005, vol. 81, no. 959, pp. 604-607.
15. Van Grevel R., Beiger M., Ottenhoff Th. et al. Possible mechanisms underlying increased susceptibility of diabetes mellitus patients to TB. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 11, suppl. 1. pp. S5.
Review
For citations:
Kaminskaya G.O., Аbdullaev R.Yu., Komissarova O.G., Konyaeva O.O., Berezhnaya O.O. Impact of concurrent diabetes on the intensity of systematic inflammatory response syndrome and nutritive status of pulmonary tuberculosis patients. Tuberculosis and Lung Diseases. 2015;(11):41-46. (In Russ.)